InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Explore the complete record of transactions filed by Ellison Mark Jason Heath, Directeur du Développement. Officer active across 1 companies, notably Opiant Pharmaceuticals, INC.. Aggregated, 3 disclosures have been published. The latest transaction was filed on 27 June 2022 (Attribution). Regulator: SEC (Form 4). All data is accessible without signup.
Declarations3 total
02,000 shares0
Common Stock
SEC:0001385508-22-000104:0·
012,000 shares0
Common Stock
SEC:0001385508-22-000011·
012,000 shares0
Common Stock
SEC:0001385508-22-000011:0·
3 of 3 declarations
About Ellison Mark Jason Heath
Mark Jason Heath Ellison is the Chief Development Officer at Opiant Pharmaceuticals, Inc. In this role, he is responsible for the business development strategy and growth of the company in the pharmaceutical sector. His expertise in product development and project management is essential for innovation and success at Opiant Pharmaceuticals. Mark Jason Heath Ellison plays a key role in expanding the company's operations.
